- Chemical Name:Mesoridazine besylate
- CAS No.:32672-69-8
- Molecular Formula:C27H32N2O4S3
- Molecular Weight:544.76
- Hs Code.:2934302300
- European Community (EC) Number:636-506-9
- NSC Number:760073
- UNII:T4G2I958J2
- DSSTox Substance ID:DTXSID10954368
- Wikidata:Q27107329
- NCI Thesaurus Code:C66101
- ChEMBL ID:CHEMBL1201052
- Mol file:32672-69-8.mol
Synonyms:MESORIDAZINE BESYLATE;32672-69-8;Mesoridazine benzenesulfonate;mesoridazine besilate;NC 123;Mesoridazine (besylate);C21H26N2OS2.C6H6O3S;10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylsulfinyl)-10H-phenothiazine benzenesulfonate;NSC-760073;Mesoridazine besylate [USP];Mesoridazine besylate [USAN];UNII-T4G2I958J2;Mesoridazine (benzenesulfonate);CHEBI:6781;32672-69-8 (besylate);T4G2I958J2;10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate;Serentil (TN);(+-)-10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate;benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine;Mesoridazine besylate (USP);Lidanar;Lidanil;10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, (+-)-, monobenzenesulfonate;10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, monobenzenesulfonate;Mesoridazine Besilate (10-[2-[(2RS)-1-Methylpiperidin-2-yl]ethyl]-2-(methylsufhinyl)-10H-phenothiazine Besilate);SMR000466274;SR-01000759425;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine benzenesulfonate;Prestwick_853;Prestwick0_000529;SCHEMBL41229;MLS000758302;MLS001424031;MLS002222270;mesoridazine monobenzenesulfonate;CHEMBL1201052;thioridazine-2-sulfoxide besylate;DTXSID10954368;HMS1569J19;HMS2051M09;HMS2096J19;HMS2234G16;HMS3369O09;HMS3393M09;HMS3713J19;HMS3885H21;Pharmakon1600-01505500;HY-B1482;MESORIDAZINE BESYLATE [VANDF];NSC760073;MESORIDAZINE BESILATE [MART.];AKOS040751129;MESORIDAZINE BESILATE [WHO-DD];MESORIDAZINE BESYLATE [USP-RS];CCG-100781;CCG-213471;NC00031;NSC 760073;LS-32028;MESORIDAZINE BENZENESULFONATE [MI];SMR000449304;MESORIDAZINE BESYLATE [ORANGE BOOK];(S)-(-)-DIAMINOPROPANETARTARICACID;MESORIDAZINE BESYLATE [USP IMPURITY];CS-0013182;SW196983-4;C21-H26-N2-O-S2.C6-H6-O3-S;D00795;J-018829;SR-01000759425-6;Mesoridazine benzenesulfonate, >=98% (HPLC), powder;Q27107329;Mesoridazine besylate, United States Pharmacopeia (USP) Reference Standard;10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylsulfinyl)-10H-phenothiazinebenzenesulfonate;(+/-)-10-(2-(1-METHYL-2-PIPERIDYL)ETHYL)-2-(METHYLSULFINYL)PHENOTHIAZINE MONOBENZENESULFONATE;(+/-)-10-(2-(1-METHYL-2-PIPERIDYL)ETHYL)-2-(METHYLSULPHINYL)PHENOTHIAZINE MONOBENZENESULPHONATE;10H-PHENOTHIAZINE, 10-(2-(1-METHYL-2-PIPERIDINYL)ETHYL)-2-(METHYLSULFINYL)-, (+/-)-, MONOBENZENESULFONATE;10H-PHENOTHIAZINE, 10-(2-(1-METHYL-2-PIPERIDINYL)ETHYL)-2-(METHYLSULPHINYL)-, (+/-)-, MONOBENZENESULPHONATE;Benzenesulfonic acid, compound with 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine (1:1);Benzenesulfonic acid--2-(methanesulfinyl)-10-[2-(1-methylpiperidin-2-yl)ethyl]-10H-phenothiazine (1/1)
